IDENTIFY STOCKS FOR VALUE INVESTING
FAQ - ANTWORTEN AUF DIE HÄUFIGSTEN FRAGEN
1. Which stocks does VIAVALENS pick to analyze?
VIAVALENS focuses on identifying undervalued companies across international equity markets. Our research includes taking a critical look at widely promoted stocks and reassessing press coverage, as well as seeking out compelling companies that are not currently receiving significant public attention.
We analyze businesses from a broad range of industries, excluding financials, real estate entities, and gold mining companies, as these are not suitable candidates for valuation via the entity approach. Listed holding companies are likewise excluded, since their market value directly reflects the aggregate value of their underlying investments.
Industry reviews often feature multiple companies from a particular sector, supporting evaluation of diversified portfolio opportunities. Valuations are performed in each company’s reporting currency, with a particular emphasis on stable, low‑inflation currency areas such as USD, EUR, CAD, JPY, GBP, CHF, SEK, DKK, HKD, SGD, KRW, and AUD.
Each VIAVALENS newsletter addresses whether purchasing a given stock is justified under value‑investing criteria.
2. What does our paid newsletter include?
Our newsletter opens with a brief profile of the featured company and a summary of recent developments. We compare our valuation outcome to the current market price as well as the stock’s 52-week high and low.
In addition to financial metrics, we highlight the key value drivers, review recent share price performance, and illustrate the evolution of business volume and earning power over the past ten fiscal years.
We reference target prices from sell-side analysts and present essential KPIs along with valuation multiples for the relevant peer group. We are fully independent and have no hesitation in pointing out material overvaluation risks, especially where warranted.
A defining feature of VIAVALENS is the full transparency we offer: our readers gain access to the entire valuation model and a detailed explanation of our approach including both the derivation of free cash flows and the components of our discount rate assumptions.
We actively welcome expert feedback and can provide our complete model upon request. Our valuation frameworks are the product of professional expertise, not machine-generated content.
3. Who authors the newsletters?
The newsletters are produced by the VIAVALENS editorial team, based on thorough analysis and the results of proprietary DCF models. While VIAVALENS provides readers with a recognizable content structure, each newsletter is entirely unique and is explicitly not generated by AI.
Wording in the general section is accessible to any investor interested in equities, while the valuation-specific section employs financial terminology as appropriate. The VIAVALENS editorial team is committed to fostering readers’ understanding of value investing and the mechanics of professional business valuation over time.
4. Who drafts the financial models?
The DCF models used by VIAVALENS are built by experienced valuation specialists from the corporate finance sector. The underlying calculations are grounded in practical application and developed with deep expertise gained from long-standing work in the financial industry.
Content direction and quality control are in the hands of professionals with over 25 years’ experience in corporate finance advisory and investment banking.
VIAVALENS welcomes constructive criticism and is happy to address qualified questions. We also maintain active dialogue with the broader valuation community.
Our raw data is sourced from professional databases and listed companies, published via their websites and in compliance with statutory disclosure obligations. Many public companies provide data for free through their investor relations sections. In addition, there is a wealth of third-party providers offering remarkably deep and high-quality financial data about companies and capital markets.
5. Can the intrinsic value differ significantly from stock price?
VIAVALENS calculates intrinsic company value as professional investors would in an acquisition scenario. The resulting per-share value can differ substantially from the quoted share price, as the market is shaped by supply, demand, and shifting sentiment. Identifying these discrepancies for investment decision-making is precisely the purpose of our valuations. History shows that market mispricings are corrected over time.
It can happen that the present value of a company’s projected future cash flows is insufficient to cover its net debt, resulting in a negative intrinsic share value.
We never fight the numbers. As independent providers, we are always prepared to publish inconvenient or contrarian analysis results.
Version 1.0 / November 2025
Copyright © 2025 VIAVALENS GmbH